Medlife International, India’s leading e-pharmacy company with about 30% market share, announced its acquisition of Medlabz, a Mumbai based Digital Healthcare platform and ‘Diagnostics at home’ services company. With this acquisition Medlife will consolidate its diagnostics business by integrating its technology platform and logistics strengths of both companies.

Medlife also announced its first state of the art Central Laboratory in Bengaluru. These combined investments are part of Medlife’s plans of offering an enhanced and seamless healthcare experience in diagnostics for Indian customers. Medlife has now become a first of its kind online pharmacy company, providing integrated services catering to all the healthcare needs of the customer - from doctor e-consultations, lab tests, health supplements, to delivery of medicines.

The Central Lab is spread over 5,000 sq. ft and is fully automated path lab including Biochemistry, Immunology, Hematology, Clinical Pathology and Cytology. The lab will provide a wide range of services ranging from Digital X Ray, 3D Ultra Sound, 2D Echo, Cardiac tests like ECG and TMT with a capability of processing nearly 10,000 tests in a single shift. With the technology integration from Medlabz, this will empower patients with data insights about their health in easy to understand language and will be made
available in their preferred language. Reports can be seen online, via app or WhatsApp.

Home sample collection will also be available through in house fleet of medical exerts with real time sample tracking.

Medlife which is currently clocking an annualized revenue run rate of Rs. 100 crore per month is expected to double it to Rs. 200 crore by March 2019 and touch Rs. 500 crore by March 2020.